Strokes with minor symptoms: An exploratory analysis of the national institute of neurological disorders and stroke recombinant tissue plasminogen activator trials

Stroke

Volumn 41, Issue 11, 2010, Pages 2581-2586

  Khatri, Pooja ^a   Kleindorfer, Dawn O ^a   Yeatts, Sharon D ^b   Saver, Jeffrey L ^c   Levine, Steven R ^d   Lyden, Patrick D ^e   Moomaw, Charles J ^a   Palesch, Yuko Y ^b   Jauch, Edward C ^b   Broderick, Joseph P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Mount Sinai Medical Center   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

acute stroke; clinical trials; thrombolysis

Indexed keywords

ALTEPLASE; PLACEBO;

AGED; ARTICLE; ATAXIA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSARTHRIA; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MINOR STROKE; MOTOR DYSFUNCTION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

AGED; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 78149360435     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.593632     Document Type: Article

References (24)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587
2. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. Ann Emerg Med. 2005;46:243-252.
3. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association/American Stroke Association Stroke Council, American Heart Association/American Stroke Association Clinical Cardiology Council, American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council, Atherosclerotic Peripheral Vascular Disease Working Group, Quality of Care Outcomes in Research Interdisciplinary Working Group. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115: e478-e534.
4. Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, Alwell K, Gebel J, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Shukla R, Broderick JP. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004;35: e27-e29.
5. Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke. 2009;40:2805-2811.
6. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hardemark HG, Rodichok L; SAINT I and II Investigators. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke. 2008;39: 1751-1758.
7. Hill MD, Moy CS, Palesch YY, Martin R, Dillon CR, Waldman BD, Patterson L, Mendez IM, Ryckborst KJ, Tamariz D, Ginsberg MD; ALIAS Investigators. The ALbumin In Acute Stroke trial (ALIAS); design and methodology. Int J Stroke. 2007;2:214-219.
8. Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ; CLEAR Trial Investigators. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke. 2008;39:3268-3276.
9. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y; Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37:1810-1815.
10. Majersik JJ, Smith MA, Zahuranec DB, Sanchez BN, Morgenstern LB. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke. 2007;38:3213-3217.
11. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015-1020.
12. Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, Diaz-Manera J, Aleu A, Pagonabarraga J, Garcia-Bargo D, Mauri A, Marti-Vilalta JL. Reasons for exclusion from thrombolytic therapy following acute ische-mic stroke. Neurology. 2005;64:719-720.
13. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283: 1151-1158.
14. George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, Hinchey J, Wall HK, Pandey DK; Centers for Disease Control and Prevention (CDC). Paul Coverdell National Acute Stroke Registry Surveillance\four states, 2005-2007. MMWR Surveill Summ. 2009; 58:1-23.
15. Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson D, Hernandez AF, Schwamm LH. Mild or improving stroke is the most frequently documented reason for not giving rt-PA in time-eligible acute ischemic stroke patients: findings from Get With The Guidelines-Stroke. 2010: accepted for poster presentation at the 2010 American Heart Association Quality of Care and Outcomes Research Conference.
16. Kleindorfer D, Broderick J, Khoury J, Flaherty M, Woo D, Alwell K, Moomaw CJ, Schneider A, Miller R, Shukla R, Kissela B. The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke. 2006;37:2473-2478.
17. Gonzales NR, Albright KC, Noser KC, Khaja AM, Shaltoni HM, Romman A, Zimbaldi N:B, MS, Moye LA, Grotta JC. 'Mild stroke' should not exclude patients from thrombolytic therapy. Stroke. 2006;37:621.
18. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke. 2005;36:2497-2499.
19. Khatri P, Khoury JC, Alwell K, Kleindorfer DO, Flaherty ML, Broderick JP, Woo D, Moomaw CJ, Kissela BM. 'Mild' ischemic strokes have substantial rates of disability at 90 days. Stroke. 2008;39.
20. Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, Marco De Marchis G, Kappeler L, Mono ML, Brekenfeld C, Schroth G, Mattle HP. What is a minor stroke? Stroke. 2010;41:661-666.
21. Tilley BC, Lyden PD, Brott TG, Lu M, Levine SR, Welch KM. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Arch Neurol. 1997;54: 1466-1474.
22. Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, Christianson TJ. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke. 2004;35:2418-2424.
23. Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, Arnold M, Remonda L, Schroth G, Mattle HP. Outcome of stroke with mild or rapidly improving symptoms. Stroke. 2007;38: 2531-2535.
24. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger JR, Villablanca P, Vinuela F, Duckwiler G, Jahan R, Fredieu A, Suzuki S, Saver JL. Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology. 2006;67:980-984.